These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 31377051)
1. Positive light on schizophrenia and aging: Commentary on course and predictors of symptomatic remission in schizophrenia: A 5-year follow-up study in a Dutch psychiatric catchment area, by Lange et al. Nguyen TT; Jeste DV Schizophr Res; 2019 Sep; 211():32-33. PubMed ID: 31377051 [No Abstract] [Full Text] [Related]
2. Course and predictors of symptomatic remission in late-life schizophrenia: A 5-year follow-up study in a Dutch psychiatric catchment area. Lange SMM; Meesters PD; Stek ML; Wunderink L; Penninx BWJH; Rhebergen D Schizophr Res; 2019 Jul; 209():179-184. PubMed ID: 31080156 [TBL] [Abstract][Full Text] [Related]
3. Symptomatic remission and associated factors in a catchment area based population of older patients with schizophrenia. Meesters PD; Comijs HC; de Haan L; Smit JH; Eikelenboom P; Beekman AT; Stek ML Schizophr Res; 2011 Mar; 126(1-3):237-44. PubMed ID: 20888190 [TBL] [Abstract][Full Text] [Related]
4. Remission in schizophrenia: a community-based 6-year follow-up study in Bali. Kurihara T; Kato M; Reverger R; Tirta IG Psychiatry Clin Neurosci; 2011 Aug; 65(5):476-82. PubMed ID: 21851456 [TBL] [Abstract][Full Text] [Related]
5. Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study. Chang WC; Ming Hui CL; Yan Wong GH; Wa Chan SK; Ming Lee EH; Hai Chen EY J Clin Psychiatry; 2013 Nov; 74(11):e1046-53. PubMed ID: 24330905 [TBL] [Abstract][Full Text] [Related]
6. One-year functional outcomes of naturalistically treated patients with schizophrenia. Spellmann I; Riedel M; Schennach R; Seemüller F; Obermeier M; Musil R; Jäger M; Schmauß M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Möller HJ Psychiatry Res; 2012 Aug; 198(3):378-85. PubMed ID: 22421065 [TBL] [Abstract][Full Text] [Related]
7. Symptomatic remission affects employment outcomes in schizophrenia patients. Wang SP; Wang JD; Chang JH; Wu BJ; Wang TJ; Sun HJ BMC Psychiatry; 2020 May; 20(1):219. PubMed ID: 32398138 [TBL] [Abstract][Full Text] [Related]
8. [Symptomatic remission and its relationship to social functioning in Tunisian out-patients with schizophrenia]. El Gharbi I; Chhoumi M; Mechri A Encephale; 2019 Feb; 45(1):15-21. PubMed ID: 29195805 [TBL] [Abstract][Full Text] [Related]
9. Symptomatic remission in previously untreated patients with schizophrenia: 2-year results from the SOHO study. Novick D; Haro JM; Suarez D; Lambert M; Lépine JP; Naber D Psychopharmacology (Berl); 2007 May; 191(4):1015-22. PubMed ID: 17310386 [TBL] [Abstract][Full Text] [Related]
10. Predictors of symptomatic remission in patients with first-episode schizophrenia: a 16years follow-up study. Marchesi C; Affaticati A; Monici A; De Panfilis C; Ossola P; Tonna M Compr Psychiatry; 2014 May; 55(4):778-84. PubMed ID: 24461689 [TBL] [Abstract][Full Text] [Related]
11. Establishing remission and good clinical functioning in schizophrenia: predictors of best outcome with long-term risperidone long-acting injectable treatment. Lambert M; De Marinis T; Pfeil J; Naber D; Schreiner A Eur Psychiatry; 2010 May; 25(4):220-9. PubMed ID: 19926263 [TBL] [Abstract][Full Text] [Related]
12. Sustained symptomatic remission in schizophrenia: Course and predictors from a two-year prospective study. Carpiniello B; Pinna F; Manchia M; Tusconi M; Cavallaro R; Bosia M Schizophr Res; 2022 Jan; 239():34-41. PubMed ID: 34839071 [TBL] [Abstract][Full Text] [Related]
13. Remission and recovery and their predictors in schizophrenia spectrum disorder: results from a 1-year follow-up naturalistic trial. Schennach R; Riedel M; Obermeier M; Jäger M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Seemüller F; Möller HJ Psychiatr Q; 2012 Jun; 83(2):187-207. PubMed ID: 22038270 [TBL] [Abstract][Full Text] [Related]
14. Predictors of early stable symptomatic remission after an exacerbation of schizophrenia: the significance of symptoms, neuropsychological performance and cognitive biases. Andreou C; Roesch-Ely D; Veckenstedt R; Bohn F; Aghotor J; Köther U; Pfueller U; Moritz S Psychiatry Res; 2013 Dec; 210(3):729-34. PubMed ID: 23998362 [TBL] [Abstract][Full Text] [Related]
15. The role of substance use and adult sexual assault severity in the course of schizophrenia: An epidemiological catchment study of sexual assault victims. Rabinovitz S; Goldman K; Rosca P; Barda J; Levine SZ Schizophr Res; 2019 Jun; 208():406-413. PubMed ID: 30654922 [TBL] [Abstract][Full Text] [Related]
16. Subjective quality of life and its determinants in a catchment area based population of elderly schizophrenia patients. Meesters PD; Comijs HC; de Haan L; Smit JH; Eikelenboom P; Beekman AT; Stek ML Schizophr Res; 2013 Jul; 147(2-3):275-80. PubMed ID: 23693066 [TBL] [Abstract][Full Text] [Related]
17. Mortality among homeless people with schizophrenia in Sydney, Australia: a 10-year follow-up. Babidge NC; Buhrich N; Butler T Acta Psychiatr Scand; 2001 Feb; 103(2):105-10. PubMed ID: 11167312 [TBL] [Abstract][Full Text] [Related]
18. [One-year follow-up and mobility assessment of schizophrenic patients in the Liege psychiatric care network]. Sarto D; Desseilles M; Martin M; Seidel L; Albert A Encephale; 2006 Oct; 32(5 Pt 1):722-8. PubMed ID: 17099596 [TBL] [Abstract][Full Text] [Related]
19. Symptomatic remission in a multiracial urban population of older adults with schizophrenia. Bankole A; Cohen CI; Vahia I; Diwan S; Palekar N; Reyes P; Sapra M; Ramirez PM Am J Geriatr Psychiatry; 2008 Dec; 16(12):966-73. PubMed ID: 19038895 [TBL] [Abstract][Full Text] [Related]